Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Doctoral College Medical Law and Healthcare, Faculty of Law, University Innsbruck, Innsbruck, Austria.
Wien Klin Wochenschr. 2020 Nov;132(21-22):653-663. doi: 10.1007/s00508-020-01764-0. Epub 2020 Nov 10.
On February 25, 2020, the first 2 patients were tested positive for severe acute respiratory syndrome coronavirus‑2 (SARS-CoV-2) in Tyrol, Austria. Rapid measures were taken to ensure adequate intensive care unit (ICU) preparedness for a surge of critically ill coronavirus disease-2019 (COVID-19) patients.
This cohort study included all COVID-19 patients admitted to an ICU with confirmed or strongly suspected COVID-19 in the State of Tyrol, Austria. Patients were recorded in the Tyrolean COVID-19 intensive care registry. Date of final follow-up was July 17, 2020.
A total of 106 critically ill patients with COVID-19 were admitted to 1 of 13 ICUs in Tyrol from March 9 to July 17, 2020. Median age was 64 years (interquartile range, IQR 54-74 years) and the majority of patients were male (76 patients, 71.7%). Median simplified acute physiology score III (SAPS III) was 56 points (IQR 49-64 points). The median duration from appearance of first symptoms to ICU admission was 8 days (IQR 5-11 days). Invasive mechanical ventilation was required in 72 patients (67.9%) and 6 patients (5.6%) required extracorporeal membrane oxygenation treatment. Renal replacement therapy was necessary in 21 patients (19.8%). Median ICU length of stay (LOS) was 18 days (IQR 5-31 days), median hospital LOS was 27 days (IQR 13-49 days). The ICU mortality was 21.7% (23 patients), hospital mortality was 22.6%. There was no significant difference in ICU mortality in patients receiving invasive mechanical ventilation and in those not receiving it (18.1% vs. 29.4%, p = 0.284). As of July 17th, 2020, two patients are still hospitalized, one in an ICU, one on a general ward.
Critically ill COVID-19 patients in Tyrol showed high severity of disease often requiring complex treatment with increased lengths of ICU and hospital stay. Nevertheless, the mortality was found to be remarkably low, which may be attributed to our adaptive surge response providing sufficient ICU resources.
2020 年 2 月 25 日,奥地利蒂罗尔州的前 2 名患者被检测出严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)呈阳性。迅速采取了措施,以确保重症监护病房(ICU)有足够的能力应对大量的 2019 年冠状病毒病(COVID-19)重症患者。
本队列研究纳入了 2020 年 3 月 9 日至 7 月 17 日期间在奥地利蒂罗尔州被确诊或高度怀疑患有 COVID-19 而入住 ICU 的所有 COVID-19 患者。患者被记录在蒂罗尔 COVID-19 重症监护登记处。最终随访日期为 2020 年 7 月 17 日。
2020 年 3 月 9 日至 7 月 17 日期间,共有 106 名 COVID-19 重症患者被收入蒂罗尔的 13 个 ICU 中的 1 个。中位年龄为 64 岁(四分位距[IQR] 54-74 岁),大多数患者为男性(76 例,71.7%)。简化急性生理学评分 III(SAPS III)中位数为 56 分(IQR 49-64 分)。从首次出现症状到入住 ICU 的中位时间为 8 天(IQR 5-11 天)。72 例(67.9%)患者需要有创机械通气,6 例(5.6%)患者需要体外膜氧合治疗。21 例(19.8%)患者需要肾脏替代治疗。ICU 住院时间中位数为 18 天(IQR 5-31 天),住院时间中位数为 27 天(IQR 13-49 天)。ICU 死亡率为 21.7%(23 例),住院死亡率为 22.6%。接受有创机械通气和未接受有创机械通气的患者 ICU 死亡率无显著差异(18.1% vs. 29.4%,p=0.284)。截至 2020 年 7 月 17 日,仍有 2 名患者住院,1 名在 ICU,1 名在普通病房。
蒂罗尔州的 COVID-19 重症患者疾病严重程度高,常需要复杂的治疗,ICU 和住院时间延长。然而,死亡率却低得惊人,这可能归因于我们的适应性激增反应提供了足够的 ICU 资源。